Pivotal Response Treatment (PRT) in Autism
Phase 2
- Conditions
- Autism Spectrum Disorder.Childhood autism
- Registration Number
- IRCT201205259854N1
- Lead Sponsor
- Vice chancellor for research, Islamic Azad University - Tonekabon Branch
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 24
Inclusion Criteria
Inclusion: 8-12 years old; diagnosis of Autism by Psychiatrist based on DSM IV; no other treatment;
Exclusion: Other neurological disorder such as cerebral palsy; seizure; metabolic disorder; change in drugs during the intervention;
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Socialization. Timepoint: Pre- intervention and 10 weeks after intervention. Method of measurement: ADI- R Questionnaire.
- Secondary Outcome Measures
Name Time Method Declining communication problems and stereotype behaviors. Timepoint: Pre- intervention and 10 weeks after intervention. Method of measurement: ADI- R Questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neurobiological pathways does Pivotal Response Treatment modulate in autism spectrum disorder boys aged 8-12?
How does Pivotal Response Treatment compare to Applied Behavior Analysis in reducing communication deficits in IRCT201205259854N1?
Which biomarkers predict response to Pivotal Response Treatment in IRCT201205259854N1's autistic male cohort?
What adverse events are reported in Pivotal Response Treatment for childhood autism and how are they managed?
How does Pivotal Response Treatment synergize with SSRIs in improving social communication in IRCT201205259854N1's autism cohort?